Am J Health Syst Pharm. 2005;62(21):2260-2264. Verify that the patient is receiving some source of exogenous glucose before initiating infusion (e.g., total parenteral nutrition [TPN], i.v. fluids ...
[18] In a retrospective study conducted by Rosmarin et al., [19] 48.6% of subjects who received TPN dextrose infusion at rates of >5 mg/ kg/min exhibited hyperglycemia, whereas none of the ...
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
1d
Home Healthcare Devices Market Aging Population, Chronic Disease Surge, and Technological Innovations Fuel Growth in Home Healthcare Device ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...
Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback